📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The first reported generation of several induced pluripotent stem cell lines from homozygous and heterozygous Huntington's disease patients demonstrates mutation related enhanced lysosomal activity. (2012)

First Author: Camnasio S

Attributed to: Wellcome Trust MRC Cambridge Stem Cell Institute funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.nbd.2011.12.042

PubMed Identifier: 22405424

Publication URI: http://europepmc.org/abstract/MED/22405424

Type: Journal Article/Review

Volume: 46

Parent Publication: Neurobiology of disease

Issue: 1

ISSN: 0969-9961